EN DE
Watch Sunway Healthcare Holdings Berhad for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Sunway Healthcare Holdings Berhad (5555) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Sunway Healthcare Holdings Berhad stock MYR 0.42, price MYR 2.09, that is 79.9% below the price, quality 58 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare MY

SH Sunway Healthcare Holdings Berhad logo Thin data Nov 6, 2026

Sunway Healthcare Holdings Berhad

5555 · KLSE
Stretched Valuation

Our calculation puts a fair price 80% below what the stock costs today.

Solidly profitable · 11.5% net margin (TTM)
Last quarter vs. a year ago: revenue +30%, profit +89%.
Quality 58/100
Mixed Growth (revenue YoY +27.2 %/yr in MYR)
Moderate debt
Mixed vs. peers (6/13)
Moderate moat 51/100 · thin data
Fair value 0.4200 MYR · Strongly overvalued
Negative free cash flow
Thin data

Risks from the AI analysis

🚩DRG payment model could cap procedure revenues🚩Flagship hospital accounts for most revenue and profit
Watch Sunway Healthcare Holdings Berhad for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

2.37 MYR 1.73 MYR Fair Value 0.4200 MYR Mar 2026 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

8‑month range 1.73 MYR – 2.37 MYR · fair‑value band 0.2900 MYR – 0.5500 MYR · the 2.09 MYR price screens above the 0.4200 MYR fair value. As of Nov 6, 2026.

Follow Sunway Healthcare Holdings Berhad in your weekly email

Every Wednesday you see whether Sunway Healthcare Holdings Berhad is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Sunway Healthcare Holdings Berhad, an investment holding company, owns and operates medical centers and facilities in Malaysia.

Show moreShow less

The company provides medical consultation services and facilities, provision of financial services, provision of nursing manpower and nursing care services, operation and provision of traditional and complementary medicine centres, provision of facilities and services for senior living care and assistance, offers ambulatory care services, invests in property, and provision of training services.

The company was incorporated in 2021 and is headquartered in Subang Jaya, Malaysia. Sunway Healthcare Holdings Berhad operates as a subsidiary of Sunway City Sdn. Bhd.

Stock analysis

Sunway Healthcare Holdings Berhad (5555) currently trades at 2.09 MYR, while our model-based Fair Value estimate is 0.4200 MYR, 80% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 0.8200 MYR per share, and 0 of the 16 models we run sit above the 2.09 MYR price.

Bear case: the Asset-Based group reads lowest at 0.1400 MYR, and 16 of the 16 models stay below the price. Data coverage for this calculation is low.

Scenario range: 0.2900 MYR (bear) to 0.5500 MYR (bull), the price of 2.09 MYR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 58/100 (solid quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Sunway Healthcare Holdings Berhad reported revenue of 1.9B MYR in FY2024 versus 1.1B MYR in FY2022, a compound +31.9%/yr. Reported net income was 258M MYR in FY2024, compounding +10.8%/yr from FY2022.

Key figures

Market cap 24.0B MYR (≈ $5.9B) Mid · P/E ratio 104.5 · P/S ratio 9.74 · EPS (TTM) 0.0200 MYR · Dividend yield 0.0% · Net margin 11.5% · Return on equity 9.3% · Return on assets (EBIT) 5.8% (3-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).

What moves the price

For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at −80%, 5555 screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (0.0100 MYR to 1.06 MYR). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear 0.2900 MYR Fair Value 0.4200 MYR Bull 0.5500 MYR
Price 2.09 MYR · Downside -79.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (0.0200 MYR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV 0.0900 MYR 0.1100 MYR 0.1300 MYR 71
Residual Income 0.1800 MYR 0.1900 MYR 0.2400 MYR 69
EV/EBITDA 0.2900 MYR 0.4200 MYR 0.5500 MYR 67
All 16 models by family
Earnings-Based
Graham-Dodd 0.1500 MYR 1.06 MYR 1.49 MYR 57
Lynch FV 0.4600 MYR 0.6600 MYR 0.8500 MYR 55
PEG = 1.0 0.4600 MYR 0.6600 MYR 0.8500 MYR 52
EPV 0.0900 MYR 0.1100 MYR 0.1300 MYR 71
Dividend Discount
Gordon GGM 0.0100 MYR 0.0100 MYR 0.0200 MYR 60
DDM Multi-Stage 0.0100 MYR 0.0100 MYR 0.0100 MYR 61
Multiples
P/E Multiple 0.3700 MYR 0.4900 MYR 0.6200 MYR 63
P/S Multiple 0.2900 MYR 0.3800 MYR 0.4800 MYR 58
P/B Multiple 0.7100 MYR 0.9500 MYR 1.19 MYR 55
EV/EBIT 0.2200 MYR 0.3200 MYR 0.4200 MYR 65
EV/EBITDA 0.2900 MYR 0.4200 MYR 0.5500 MYR 67
EV/Revenue 0.1300 MYR 0.2200 MYR 0.3200 MYR 52
Asset-Based
NCAV (Graham) 0.1100 MYR 0.1400 MYR 0.2100 MYR 54
Economic Profit
Residual Income 0.1800 MYR 0.1900 MYR 0.2400 MYR 69
ROIC Compounder 0.0900 MYR 0.1100 MYR 0.1300 MYR 66
Growth Earnings
Growth-Adj P/E 0.5800 MYR 0.8200 MYR 1.07 MYR 61

Open the full fair value analysis →

Quality Score breakdown

Overall quality 58/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 43
How much profit the company makes from its sales and capital
Quality Growth 70
Are margins and returns getting better?
Cashflow 39
Do the profits arrive as real cash?
Financial strength 75
Debt, balance sheet and risk of trouble
Investment 38
Does it invest with discipline instead of growing at any price?
Low Volatility 62
How calm the share price moves, does not count
Price momentum 53
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 48
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 49/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed

5555 screens overvalued: fair value 80% below the price. Compare with HCA Healthcare, Inc →

Compare Sunway Healthcare Holdings Berhad with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 234 stocks

Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 58 · Above median
Fair Value upside −79.9% · Bottom 25%
Profitability
Return on equity (12 months) 9.3% · Above median
Return on assets 5.4% · Above median
Net margin (12 months) 11.5% · Above median
Operating margin (12 months) 14.8% · Above median
Growth and dividend
Revenue growth (quarter YoY) 29.8% · Top 25%
Dividend yield (12 months) 0.0% · Bottom 25%
Balance sheet
Debt / equity 0.52× · Highest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (12 months) 104.5× · Priciest 25%
P/B 9.76× · Priciest 25%
P/S (12 months) 9.74× · Priciest 25%
EV/EBITDA 46.1× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 34
FUTURE (revenue growth)100 · sector 31
PAST (return on equity)37 · sector 33
HEALTH (low debt)74 · sector 90
DIVIDEND (yield)1 · sector 39

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $23.40 $46.55 +99% vs 5555
Aier Eye Hospital Group 300015 ¥9.01 ¥10.88 +21% vs 5555
DaVita Inc DVA $191.35 $218.90 +14% vs 5555
HCA Healthcare, Inc HCA $494.99 $547.34 +11% vs 5555
Tenet Healthcare Corporation THC $283.33 $279.20 −1% vs 5555
The Ensign Group ENSG $181.08 $140.09 −23% vs 5555
Encompass Health Corporation EHC $137.54 $94.81 −31% vs 5555
Fresenius SE FRE €52.48 €34.77 −34% vs 5555
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,446 ₹5,234 −38% vs 5555
Dr. Sulaiman Al Habib Medical Services Group 4013 215.00 SAR 109.45 SAR −49% vs 5555

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Sunway Healthcare Holdings Berhad: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Sunway Healthcare Holdings Berhad Fair Value". https://www.fairvalue-calculator.com/stock/5555

Frequently asked questions

Is Sunway Healthcare Holdings Berhad (5555) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of 0.4200 MYR versus a price of 2.09 MYR, about 80% lower (overvalued).
What is the fair value of 5555?
Our model-based fair value for Sunway Healthcare Holdings Berhad is 0.4200 MYR (as of Nov 6, 2026), built from audited fundamentals. The current price: 2.09 MYR.
What is the quality score of 5555?
Sunway Healthcare Holdings Berhad has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sunway Healthcare Holdings Berhad (5555)?
Our model-based price target is the fair value of 0.4200 MYR (as of Nov 6, 2026) from 16 valuation models. Cautious scenario 0.2900 MYR, optimistic scenario 0.5500 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Sunway Healthcare Holdings Berhad stock forecast for 2026?
Our models put fair value at 0.4200 MYR, about 80% lower versus a price of 2.09 MYR (overvalued). Cautious scenario 0.2900 MYR, optimistic scenario 0.5500 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Sunway Healthcare Holdings Berhad (5555)?
Sunway Healthcare Holdings Berhad reported trailing-twelve-month revenue of about 2.5B MYR (latest available figure, as of Nov 6, 2026).
Does Sunway Healthcare Holdings Berhad pay a dividend?
Sunway Healthcare Holdings Berhad currently shows a dividend yield of 0.05% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Sunway Healthcare Holdings Berhad (5555)?
Sunway Healthcare Holdings Berhad has a dividend yield of 0.0%.
What is the intrinsic value of Sunway Healthcare Holdings Berhad (5555)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sunway Healthcare Holdings Berhad it is 0.4200 MYR per share (as of Nov 6, 2026), against a price of 2.09 MYR. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Sunway Healthcare Holdings Berhad stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 5555 trades above its calculated fair value: price 2.09 MYR, fair value 0.4200 MYR, a gap of about −80% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 5555?
No. The price is what the market pays today (2.09 MYR); the fair value is what the company's own numbers justify (0.4200 MYR). For Sunway Healthcare Holdings Berhad the two are 1.67 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Sunway Healthcare Holdings Berhad worth?
The market values Sunway Healthcare Holdings Berhad at about 24.0B MYR (market capitalisation, as of Nov 6, 2026). Per share that is 2.09 MYR; our models calculate a fair value of 0.4200 MYR per share.
What do the bullish and bearish scenarios say about 5555?
Our models span a range for Sunway Healthcare Holdings Berhad: cautious scenario 0.2900 MYR, base 0.4200 MYR, optimistic 0.5500 MYR per share (as of Nov 6, 2026, price 2.09 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 5555?
Sunway Healthcare Holdings Berhad trades at a price-to-earnings ratio of 104.5 (as of Nov 6, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.4200 MYR is built from several models across several years. Other multiples: P/B 9.8, P/S 9.7, EV/EBITDA 46.1.
How solid is the balance sheet of Sunway Healthcare Holdings Berhad (5555)?
Balance-sheet figures for Sunway Healthcare Holdings Berhad (as of Nov 6, 2026): return on equity 9.3%, debt of 0.52 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
Which stocks are comparable to Sunway Healthcare Holdings Berhad?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sunway Healthcare Holdings Berhad stock attractive at the current price?
The data as of Nov 6, 2026: price 2.09 MYR, calculated fair value 0.4200 MYR (−80%), Quality Score 58/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 5555 calculated?
We run Sunway Healthcare Holdings Berhad through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 0.4200 MYR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Sunway Healthcare Holdings Berhad itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sunway Healthcare Holdings Berhad (5555)?
The closing price on Nov 6, 2026 was 2.09 MYR. Our model-based fair value is 0.4200 MYR, about 80% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sunway Healthcare Holdings Berhad right now?
The price sits above even our optimistic bull case (0.5500 MYR). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (58/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (0.2900 MYR to 0.5500 MYR) leaves room in how you read the outcome.

Key figures of Sunway Healthcare Holdings Berhad

How large is the market capitalisation of Sunway Healthcare Holdings Berhad (5555)?
The market capitalisation of Sunway Healthcare Holdings Berhad is 24.0B MYR (≈ $5.9B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sunway Healthcare Holdings Berhad (5555)?
The price-to-sales ratio of Sunway Healthcare Holdings Berhad is 9.74 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sunway Healthcare Holdings Berhad (5555)?
Earnings per share at Sunway Healthcare Holdings Berhad are 0.0200 MYR (price ÷ EPS = P/E 104.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Sunway Healthcare Holdings Berhad (5555)?
The dividend yield of Sunway Healthcare Holdings Berhad is 0.0% (payout 4.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Sunway Healthcare Holdings Berhad (5555)?
The net margin of Sunway Healthcare Holdings Berhad is 11.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sunway Healthcare Holdings Berhad (5555)?
The return on equity (ROE) of Sunway Healthcare Holdings Berhad is 9.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sunway Healthcare Holdings Berhad (5555)?
On an EBIT basis the return on assets of Sunway Healthcare Holdings Berhad is 5.8% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sunway Healthcare Holdings Berhad (5555)?
The operating margin of Sunway Healthcare Holdings Berhad is 14.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sunway Healthcare Holdings Berhad (5555)?
Revenue at Sunway Healthcare Holdings Berhad is growing +29.8% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sunway Healthcare Holdings Berhad (5555)?
Earnings per share at Sunway Healthcare Holdings Berhad are growing +88.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Sunway Healthcare Holdings Berhad (5555) generate?
The free cash flow of Sunway Healthcare Holdings Berhad is −118M MYR (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Sunway Healthcare Holdings Berhad (5555) carry?
The net debt of Sunway Healthcare Holdings Berhad is 1.0B MYR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Sunway Healthcare Holdings Berhad in the live analysis

One click puts Sunway Healthcare Holdings Berhad on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.